Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated:  9/1/2015
C.S. Mott Children's Hospital at University of Michigan Medical Center
mi
from
Ann Arbor, MI
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated: 9/1/2015
C.S. Mott Children's Hospital at University of Michigan Medical Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated:  9/1/2015
Barbara Ann Karmanos Cancer Institute
mi
from
Detroit, MI
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated: 9/1/2015
Barbara Ann Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated:  9/1/2015
Van Elslander Cancer Center at St. John Hospital and Medical Center
mi
from
Grosse Pointe Woods, MI
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated: 9/1/2015
Van Elslander Cancer Center at St. John Hospital and Medical Center
mi
from
Grosse Pointe Woods, MI
Click here to add this to my saved trials
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated:  9/1/2015
Children's Hospitals and Clinics of Minnesota - Minneapolis
mi
from
Minneapolis, MN
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated: 9/1/2015
Children's Hospitals and Clinics of Minnesota - Minneapolis
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated:  9/1/2015
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated: 9/1/2015
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated:  9/1/2015
University of Mississippi Cancer Clinic
mi
from
Jackson, MS
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated: 9/1/2015
University of Mississippi Cancer Clinic
mi
from
Jackson, MS
Click here to add this to my saved trials
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated:  9/1/2015
Ellis Fischel Cancer Center at University of Missouri - Columbia
mi
from
Columbia, MO
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated: 9/1/2015
Ellis Fischel Cancer Center at University of Missouri - Columbia
mi
from
Columbia, MO
Click here to add this to my saved trials
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated:  9/1/2015
Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
mi
from
St. Louis, MO
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated: 9/1/2015
Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
mi
from
St. Louis, MO
Click here to add this to my saved trials
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated:  9/1/2015
CCOP - Nevada Cancer Research Foundation
mi
from
Las Vegas, NV
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated: 9/1/2015
CCOP - Nevada Cancer Research Foundation
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated:  9/1/2015
John Theurer Cancer Center
mi
from
Hackensack, NJ
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated: 9/1/2015
John Theurer Cancer Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated:  9/1/2015
Newark Beth Israel Medical Center
mi
from
Newark, NJ
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated: 9/1/2015
Newark Beth Israel Medical Center
mi
from
Newark, NJ
Click here to add this to my saved trials
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated:  9/1/2015
University of New Mexico Cancer Center
mi
from
Albuquerque, NM
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated: 9/1/2015
University of New Mexico Cancer Center
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated:  9/1/2015
Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center
mi
from
New York, NY
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated: 9/1/2015
Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated:  9/1/2015
Mission Hospitals - Memorial Campus
mi
from
Asheville, NC
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated: 9/1/2015
Mission Hospitals - Memorial Campus
mi
from
Asheville, NC
Click here to add this to my saved trials
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated:  9/1/2015
Akron Children's Hospital
mi
from
Akron, OH
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated: 9/1/2015
Akron Children's Hospital
mi
from
Akron, OH
Click here to add this to my saved trials
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated:  9/1/2015
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated: 9/1/2015
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated:  9/1/2015
Nationwide Children's Hospital
mi
from
Columbus, OH
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated: 9/1/2015
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated:  9/1/2015
Medical University of Ohio Cancer Center
mi
from
Toledo, OH
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated: 9/1/2015
Medical University of Ohio Cancer Center
mi
from
Toledo, OH
Click here to add this to my saved trials
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated:  9/1/2015
Oklahoma University Cancer Institute
mi
from
Oklahoma City, OK
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated: 9/1/2015
Oklahoma University Cancer Institute
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated:  9/1/2015
Knight Cancer Institute at Oregon Health and Science University
mi
from
Portland, OR
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated: 9/1/2015
Knight Cancer Institute at Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated:  9/1/2015
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated: 9/1/2015
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated:  9/1/2015
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated: 9/1/2015
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated:  9/1/2015
Hollings Cancer Center at Medical University of South Carolina
mi
from
Charleston, SC
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated: 9/1/2015
Hollings Cancer Center at Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated:  9/1/2015
East Tennessee Children's Hospital
mi
from
Knoxville, TN
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated: 9/1/2015
East Tennessee Children's Hospital
mi
from
Knoxville, TN
Click here to add this to my saved trials
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated:  9/1/2015
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated: 9/1/2015
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated:  9/1/2015
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated: 9/1/2015
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated:  9/1/2015
Driscoll Children's Hospital
mi
from
Corpus Christi, TX
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated: 9/1/2015
Driscoll Children's Hospital
mi
from
Corpus Christi, TX
Click here to add this to my saved trials
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated:  9/1/2015
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
mi
from
Dallas, TX
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated: 9/1/2015
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated:  9/1/2015
Cook Children's Medical Center - Fort Worth
mi
from
Fort Worth, TX
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated: 9/1/2015
Cook Children's Medical Center - Fort Worth
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated:  9/1/2015
Baylor University Medical Center - Houston
mi
from
Houston, TX
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated: 9/1/2015
Baylor University Medical Center - Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated:  9/1/2015
M. D. Anderson Cancer Center at University of Texas
mi
from
Houston, TX
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated: 9/1/2015
M. D. Anderson Cancer Center at University of Texas
mi
from
Houston, TX
Click here to add this to my saved trials
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated:  9/1/2015
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated: 9/1/2015
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated:  9/1/2015
Children's Hospital and Regional Medical Center - Seattle
mi
from
Seattle, WA
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated: 9/1/2015
Children's Hospital and Regional Medical Center - Seattle
mi
from
Seattle, WA
Click here to add this to my saved trials
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated:  9/1/2015
Providence Cancer Center at Sacred Heart Medical Center
mi
from
Spokane, WA
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated: 9/1/2015
Providence Cancer Center at Sacred Heart Medical Center
mi
from
Spokane, WA
Click here to add this to my saved trials
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated:  9/1/2015
Midwest Children's Cancer Center at Children's Hospital of Wisconsin
mi
from
Milwaukee, WI
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated: 9/1/2015
Midwest Children's Cancer Center at Children's Hospital of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated:  9/1/2015
Princess Margaret Hospital for Children
mi
from
Perth,
Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Pharmacokinetics of Daunomycin in Children
Status: Enrolling
Updated: 9/1/2015
Princess Margaret Hospital for Children
mi
from
Perth,
Click here to add this to my saved trials
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
Alaska Clinical Research Center, LLC
mi
from
Anchorage, AK
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
Alaska Clinical Research Center, LLC
mi
from
Anchorage, AK
Click here to add this to my saved trials
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
Pinnacle Oncology Hematology
mi
from
Scottsdale, AZ
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
Pinnacle Oncology Hematology
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
Arizona Cancer Center
mi
from
Tucson, AZ
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
Arizona Cancer Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
Desert Hematology Oncology
mi
from
Rancho Mirage, CA
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
Desert Hematology Oncology
mi
from
Rancho Mirage, CA
Click here to add this to my saved trials
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
Pacific Hematology Oncology Associates
mi
from
San Francisco, CA
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
Pacific Hematology Oncology Associates
mi
from
San Francisco, CA
Click here to add this to my saved trials
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
George Washington University
mi
from
Washington,
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
George Washington University
mi
from
Washington,
Click here to add this to my saved trials
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
Lynn Cancer Institute Center For Hematology-Oncology
mi
from
Boca Raton, FL
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
Lynn Cancer Institute Center For Hematology-Oncology
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
Baptist Cancer Institute
mi
from
Jacksonville, FL
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
Baptist Cancer Institute
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
Mount Sinai Comprehensive Cancer Center
mi
from
Miami Beach, FL
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
Mount Sinai Comprehensive Cancer Center
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
M.D. Anderson Cancer Center at Orlando
mi
from
Orlando, FL
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
M.D. Anderson Cancer Center at Orlando
mi
from
Orlando, FL
Click here to add this to my saved trials
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
Straub Clinic And Hospital
mi
from
Honolulu, HI
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
Straub Clinic And Hospital
mi
from
Honolulu, HI
Click here to add this to my saved trials
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
University of Chicago
mi
from
Chicago, IL
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
Cancer Care Specialists of Central Illinois
mi
from
Decatur, IL
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
Cancer Care Specialists of Central Illinois
mi
from
Decatur, IL
Click here to add this to my saved trials
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
Hutchinson Clinic
mi
from
Hutchinson, KA
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
Hutchinson Clinic
mi
from
Hutchinson, KA
Click here to add this to my saved trials